A PHASE 3, DOUBLE-BLIND, PLACEBO-AND ACTIVE-CONTROLLED DOSE RANGE-FINDING EFFICACY AND SAFETY STUDY OF PRELADENANT IN SUBJECTS WITH EARLY PARKINSON´S DISEASE (PHASE 3 PROTOCOL N°. P05664)

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: 01f27a6f620033c58a9ba05027d0dc4eb7567e93
First added on: Apr 16, 2025